Navigation Links
Television Actor Who Has Portrayed a Doctor and an Investigator Lends Support to Fundraiser for the Toughest Children's Cancer
Date:5/6/2008

NEW YORK, May 6 /PRNewswire-USNewswire/ -- Melina Kanakaredes portrayed a doctor in her hit show, Providence. On CSI: NY she's a relentless investigator. So it's fitting she serve as mistress of ceremonies for the Children's Brain Tumor Foundation 6th Annual Dream & Promise Gala that raises funds to support medical investigation into one of the toughest and most challenging children's cancer; brain and spinal cord tumors. The Gala will take place tonight at 6:30 p.m. at the Marriott Marquis in Times Square in New York City.

The Gala this year honors three individuals who have made substantive contributions to children facing medical challenges. Dr. Larry Kun will receive the Pioneer Award for Pediatric Radiation Oncology to honor his efforts at St. Jude Children's Research Hospital. Dr. Thomas Koestler, Executive Vice President, Schering-Plough Corporation and President of the Schering-Plough Research Institute, along with Peter M. Kash, Chairman of Two River Group Holding, LLC will also be recognized. Dr. Koestler guides the strategic direction of product development programs and oversees the movement of projects through the discovery, development, registration and launch phases at Schering-Plough. Mr. Kash sits on the boards of several not-for-profit organizations, including Keren-Or, which supports blind and multi-handicapped children.

Speaking about his award, Dr. Kun remarked, "I am delighted to participate in the Children's Brain Tumor Foundation Benefit, recognizing the central role the CBTF has played in both national advocacy and support for research in childhood brain tumors. I am truly honored by the Foundation's recognition and look forward to joining those who have committed considerable time and effort in promoting the goals of the CBTF."

Stuart Essig, CEO and President of Integra LifeSciences and last year's corporate honoree comments, "I am honored to be a co-chair of the Foundation's 2008 Gala and am very proud of the s
'/>"/>

SOURCE Children's Brain Tumor Foundation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. UPDATE: Retirement Living TV Partners With Maryland Public Television to Address the Issue of Healthcare in America Through Its Series Healthcare 08: Search for Solutions
2. Lifetime Television Proudly Announces October Marquee Event Original Movie, Living Proof Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr.
3. Sharing Miracles Television Program to Feature Leave it to Beaver Star Jerry Mathers
4. Retirement Living TV Partners with Maryland Public Television to Address the Issue of Healthcare in America Through Its Series Healthcare 08: Search for Solutions
5. Settlement Reached Between Motion Picture & Television Fund and SEIU UHW
6. Sharing Miracles Television Program to Feature Emmy Award-Winning Actor Joey Pantoliano
7. Caregivers to the Stars Light Up the Night; Healthcare Professionals Organize Candlelight Vigil to Prevent a Strike at Motion Picture and Television Fund Hospital
8. Sharing Miracles Television Program to Feature Mountain Climber and Cancer Survivor Sean Swarner
9. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
10. Interactive Patient Television Drives Patient Satisfaction, LodgeNet Healthcare Study Shows
11. Lifetime Television Launches Third Annual Dont Skip a Beat Multi-Platform Heart Health Awareness Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2008)...sed skin health program, the first of its kind, ad...es affecting an increasingly diverse,America, airi...ay 24, 2008., SAN FRANCISCO, May 20 /PRNewswire/ ...esigned to educate and inform the public about the...omen,s Dermatologic Society (WDS),is pleased to an...
(Date:5/20/2008)... C is a health care problem all over the world, wi...he treatment is expensive and has variable results... The first land mark in treatment is the virus cle...tment Response (ETR), but many of the patients ach...months. Thus, the goal of treatment is to have per...
(Date:5/20/2008)...s to Aid America,s Wounded Warriors Facing Combat-... with Traumatic Brain Injury, WASHINGTON, May 20 ...elated vision loss have been among the most common...airmen and Marines serving in Iraq and,Afghanistan...er in,Washington, D.C., U.S. Rep. John Boozman, O....
(Date:5/20/2008)...ew England,s largest fertility clinics expands to ...e/ -- Reproductive Science Center,(RSC) of New Eng...kind,nationwide, announces a new partnership with ...ertility clinic at the hospital,s satellite facili... 250., Dr. Ania Kowalik, board-certified reproduc...
Breaking Medicine News(10 mins):Health News:Women's Dermatologic Society Announces Collaboration on 'America's Ethnic Skin: An Al Roker Health Special' 2Health News:Women's Dermatologic Society Announces Collaboration on 'America's Ethnic Skin: An Al Roker Health Special' 3Health News:Rep. Boozman, AOA Officials Tour Military Eye Care Facilities at Walter Reed Army Medical Center 2Health News:Rep. Boozman, AOA Officials Tour Military Eye Care Facilities at Walter Reed Army Medical Center 3Health News:Rep. Boozman, AOA Officials Tour Military Eye Care Facilities at Walter Reed Army Medical Center 4Health News:Reproductive Science Center and Lowell General Hospital Announce Partnership in Infertility Treatment 2
...mber of foreign-born health care workers in the Un...ansmitting tuberculosis in health-care settings.//...ts Timothy R. Sterling, M.D., and David W. Haas, M...ealth care workers with latent TB infection as ind...
...s who has a distinct edge joined the debate with m...'s brain suit inherently better for science than w... the similarities and differences among the gender...res' experience as a female-to-male transgendered ...
...ed by Australian researchers has discovered a new ...acid binding protein in human airway epithelial ce...ion. The researchers had explained in their stu... acid–binding protein aP2, which is known to regul...
...ts who consider suicide fail to seek help from a d...e who do ask for help may find it difficult to obt...to a new study. "We need to improve access to tre...n," said Ruth Klap, Ph.D., a sociologist at Univer...
Other Medicine News:Health News:Transgender Experience - A Tool to Analyze Gender Difference By Stanford Scientist 2Health News:Transgender Experience - A Tool to Analyze Gender Difference By Stanford Scientist 3Health News:Transgender Experience - A Tool to Analyze Gender Difference By Stanford Scientist 4Health News:Study Says - Blocking 'aP2' Protein Prevents Airway Diseases 2Health News:Many Suicidal Adults Aren't Getting Mental Health Treatment 2
(Date:5/19/2008)...ladder Replacement Structurally Similar to, Native...ress Briefing and Post... May 19 /- Tengion,Inc., a clinical ...ment of,neo-organs and neo-vessels, presented prec...Replacement(TM) at the Annual Meeting of the Ameri...
(Date:5/19/2008)...swire/ -- Ikaria Holdings, Inc., a fully,integrate... today that it,has completed dosing of its Phase 1...lfide) for injection., The study was a Phase 1, r...e center dose escalation study of a single bolus i...s safety, tolerability and pharmacokinetics.,The s...
(Date:5/19/2008)...RNewswire/ -- IPSOGEN SA (Marseille and New,Haven)...cular diagnostic,assays for blood & breast cancers...sity of Texas MD Anderson Cancer Center (MDACC, Ho... on the Genomic Grade index (GGi) at the,ASCO Annu... 2008. The data,indicate that the Genomic Grade in...
(Date:5/18/2008)...ome fair coloring traits contribute to risk, of sk...CODEme(TM) service, REYKJAVIK, Iceland, May 18 /P...E scientists and academic colleagues from Europe a...ngs in the genetics of pigmentation,traits in peop...in of these,common variants also confer risk of tw...
Breaking Medicine Technology:Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM) 2Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection 2Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection 3Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 2Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 3Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 4deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 2deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 3deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer 4NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7 2008 5112 1NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7 2008 5112 2Myanmar Cyclone 3A Women and Children Make up More than Half of Victims UNICEF 18473 1Myanmar Cyclone 3A Women and Children Make up More than Half of Victims UNICEF 18473 2West Coast Bank Sponsors Reach the Beach Cycling Fundraiser to Support the American Lung Association 18468 1West Coast Bank Sponsors Reach the Beach Cycling Fundraiser to Support the American Lung Association 18468 2Healthcare Realty Trust Announces First Quarter Results 18463 1Healthcare Realty Trust Announces First Quarter Results 18463 2Healthcare Realty Trust Announces First Quarter Results 18463 3Healthcare Realty Trust Announces First Quarter Results 18463 4Healthcare Realty Trust Announces First Quarter Results 18463 5Healthcare Realty Trust Announces First Quarter Results 18463 6Healthcare Realty Trust Announces First Quarter Results 18463 7Healthcare Realty Trust Announces First Quarter Results 18463 8
...May 14, 2007 - Acceleron Pharma,Inc., a biopharma...reatment of musculoskeletal, metabolic and cancer-...clinical study with,ACE-031 that demonstrated the ...d strength in normal mice and in murine models of,...lators of muscle,to increase muscle mass and stren...
...rket dynamics offers insights into,what will be ne...ients, NEW YORK, May 14, 2007 /PRNewswire-USNewsir...(TB Alliance), a not-for-profit,product developme...lopment of new TB drugs, today released results fr...f the global TB drug market,that offers a detailed...
Other Medicine Technology:Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies 2Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies 3New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 2New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 3New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 4
Siemens Webcast: Expert Insight - Key Elements for a Successful Electrophysiology Program
...LEXILOG antimony pH catheters are designed for pat...ll catheters are number marked at 5cm intervals an...en individual models are available spanning most c...se or multi-use models with one or two sensors., ...
...limline multi-use catheters are designed using est...ution with the following benefits:, ,Working with...res where the multi-use catheter is used the Helli...n.,NOTE: ,Medtronic pH measurement systems have be...
FLEXILOG spare part.
Medicine Products: